William C. Campbell
Who was William C. Campbell?
Nobel laureate: Nobel Prize in Physiology or Medicine (2015)
Biographical data adapted from Wikipedia’s article on William C. Campbell (CC BY-SA 4.0).
Biography
William Cecil Campbell was born on June 28, 1930, in Ramelton, County Donegal, Ireland. He studied at Trinity College Dublin, the University of Dublin, and later at the University of Wisconsin–Madison. This international education played a key role in shaping his scientific career and research approach.
Campbell was a microbiologist known for his work on parasitic diseases. He joined the Merck Institute for Therapeutic Research in 1957, where he spent more than 30 years doing pioneering research. At Merck, he worked on finding treatments for parasitic infections affecting humans and animals, focusing on roundworm infections, which were a major health issue worldwide.
Campbell's career highlight was his role in discovering avermectins, a group of drugs that changed the treatment of parasitic diseases. These drugs were extremely effective against conditions like River blindness and Lymphatic filariasis. River blindness caused widespread blindness in tropical areas, while lymphatic filariasis led to severe swelling and disability for millions globally.
After retiring from Merck in 1990, Campbell continued working as a research fellow emeritus at Drew University. He gained international acclaim when he was awarded the 2015 Nobel Prize in Physiology or Medicine for his work on roundworm infection treatments. The Nobel Committee praised his development of therapies that had a huge impact on global health, especially in developing nations struggling with endemic parasitic diseases.
Beyond the Nobel Prize, Campbell's achievements earned him a fellowship in the Royal Society in 2020, one of the highest scientific honors. His career highlights the blend of research and practical use, showing how lab discoveries can turn into life-saving treatments for millions. His work has been especially important in tropical medicine and veterinary fields, where parasitic infections are a constant problem.
Before Fame
Campbell grew up in rural Ireland when the country was becoming independent and building up its educational institutions. He went to school in the 1940s and 1950s when Ireland was putting a lot into scientific education and research. Like many Irish scientists, he chose to study both in Ireland and abroad to gain international experience to go along with his local education.
His path to specializing in parasitology was influenced by the post-World War II growth of pharmaceutical research. In the 1950s, as Campbell finished his education and started his career, the pharmaceutical industry was expanding rapidly due to the success of antibiotics and new drug discovery efforts. His move to the United States and job at Merck put him at the leading edge of this growing area of therapeutic research.
Key Achievements
- Co-discovery of avermectins, a revolutionary class of anti-parasitic drugs
- Joint recipient of the 2015 Nobel Prize in Physiology or Medicine
- Development of treatments for River blindness that have prevented millions of cases of blindness
- 33-year career at Merck Institute for Therapeutic Research contributing to pharmaceutical innovation
- Election as Fellow of the Royal Society in 2020
Did You Know?
- 01.Campbell holds both Irish and American citizenship, reflecting his international career spanning multiple decades
- 02.The avermectin drugs he helped discover are also widely used in veterinary medicine, particularly for treating parasites in livestock and pets
- 03.His work on River blindness treatments has been distributed free of charge in affected regions through international health programs
- 04.Campbell was 85 years old when he received the Nobel Prize, making him one of the older recipients of this honor
- 05.The town of Ramelton where he was born has a population of fewer than 1,500 people
Awards & Honors
| Award | Year | Details |
|---|---|---|
| Nobel Prize in Physiology or Medicine | 2015 | for their discoveries concerning a novel therapy against infections caused by roundworm parasites |
| Fellow of the Royal Society | 2020 | — |